Great West Life Assurance CO Arcturus Therapeutics Holdings Inc. Transaction History

Great West Life Assurance CO

$53.1 Billion
Q2 2024

A detailed history of Great West Life Assurance CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 5,349 shares of ARCT stock, worth $110,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,349

Previous 4,492 19.08%

Holding current value

$110,991

Previous $152,000 14.47%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$24.35 - $44.39 $20,867 - $38,042	857 Added 19.08%	5,349 $130,000
Q1 2024 May 13, 2024	BUY	$31.23 - $42.99 $13,366 - $18,399	428 Added 10.53%	4,492 $152,000
Q4 2023 Feb 13, 2024	SELL	$17.71 - $32.97 $6,039 - $11,242	-341 Reduced 7.74%	4,064 $127,000
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $46,428 - $68,163	1,825 Added 70.74%	4,405 $112,000
Q2 2023 Aug 10, 2023	SELL	$23.94 - $32.36 $2,370 - $3,203	-99 Reduced 3.7%	2,580 $74,000
Q1 2023 May 12, 2023	BUY	$14.72 - $23.97 $9,067 - $14,765	616 Added 29.86%	2,679 $64,000
Q4 2022 Feb 10, 2023	BUY	$14.14 - $23.06 $3,492 - $5,695	247 Added 13.6%	2,063 $35,000
Q3 2022 Nov 01, 2022	BUY	$13.05 - $22.13 $23,698 - $40,188	1,816 New	1,816 $27,000
Q2 2022 Aug 09, 2022	BUY	$12.26 - $31.17 $2,280 - $5,797	186 Added 12.71%	1,649 $26,000
Q1 2022 May 12, 2022	BUY	$17.64 - $39.57 $2,646 - $5,935	150 Added 11.42%	1,463 $41,000
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $4,959 - $6,896	145 Added 12.41%	1,313 $48,000
Q2 2020 Aug 17, 2020	BUY	$12.66 - $58.27 $14,786 - $68,059	1,168 New	1,168 $54,000

Others Institutions Holding ARCT

# of Institutions

186

Shares Held

25.9M

Call Options Held

320K

Put Options Held

153K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $551M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Arcturus Therapeutics Holdings Inc. Transaction History